Drug Type Gene therapy |
Synonyms |
Target |
Mechanism FGF21 agonists(Fibroblast growth factor 21 agonists), TGF-β1 modulators(Transforming growth factor beta 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Rejuvenate Bio, Inc.Startup |
Active Organization Rejuvenate Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
disorder of aging | Preclinical | US | Rejuvenate Bio, Inc.Startup | - |
Heart Diseases | Preclinical | US | Rejuvenate Bio, Inc.Startup | - |
Kidney Diseases | Preclinical | US | Rejuvenate Bio, Inc.Startup | - |
Metabolic Diseases | Preclinical | US | Rejuvenate Bio, Inc.Startup | - |